arrow
R

Rohit Jain

Medical University of Vienna
H指数:41
被引数:9,012

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A CD4-lineage erythro–myeloid progenitor within the adult bone marrow defines an alternative pathway for macrophage generation

CD4谱系红系-髓系祖细胞定义了成体骨髓中巨噬细胞生成的替代途径

2026-10-260
OAAI
The maternal–fetal interface is an early hematopoietic niche enriched in distinct erythro-myeloid progenitors

母胎界面是富集特定红系-髓系祖细胞的早期造血微环境

2026-10-260
OAAI
CSF1R-dependent CD169-positive macrophages locally constrain melanoma growth in the skin

CSF1R依赖的CD169阳性巨噬细胞在皮肤中局部抑制黑色素瘤生长

2026-05-011
PRE
Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancer

Ib期研究:恩扎卢胺联合维奈克拉用于转移性去势抵抗性前列腺癌患者的治疗

2025-11-290
OAAI
Fever in Myocardial Infarction-Related Cardiogenic Shock

心肌梗死相关的心源性休克中的发热

2025-10-010
OAAI
Mast cells activated in vitro can modulate macrophage polarization and antibacterial responses

体外活化的肥大细胞可以调节巨噬细胞极化和抗菌反应

2025-05-260
OAAI
Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial
2024-11-091
PRE
Mast cell-derived BH4 and serotonin are critical mediators of postoperative pain

肥大细胞衍生的BH4和5-羟色胺是术后疼痛的关键介质

2024-08-234
PRE
PrECOG PrE0807: A Phase 1b Feasibility Trial of Neoadjuvant Nivolumab Without and with Lirilumab in Patients with Muscle-invasive Bladder Cancer Ineligible for or Refusing Cisplatin-based Neoadjuvant Chemotherapy
2024-08-015
PRE
A plain language summary of the TROPHY-U-01 study: sacituzumab govitecan use in people with locally advanced or metastatic urothelial cancer
2024-06-050
PRE
JAK-STAT signaling maintains homeostasis in T cells and macrophages
2024-04-246
OAAI
TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinumbased chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes

TROPHY-U-01,sacituzumab govitecan用于铂化疗和检查点抑制剂后进展的转移性尿路上皮癌患者的II期开放标签研究: 更新的安全性和有效性结果

2024-04-0117
OAAI
Invasion- Block and S- MARVEL: A high- content screening and image analysis platform identifies ATM kinase as a modulator of melanoma invasion and metastasis

侵袭阻滞和s-marvel: 高含量的筛选和图像分析平台将ATM激酶鉴定为黑色素瘤侵袭和转移的调节剂

2023-11-141
OAAI
Combination of nivolumab with standard of care in the management of grade group 5 prostate cancer: Interim analysis of a phase II trial
2023-04-141
PRE
Germline and somatic genomic profiling of urothelial carcinoma
2023-04-040
PRE